J Knitza1, D Vossen2, I Geffken2, M Krusche3, M Meyer3, P Sewerin4, A Kleyer5, A J Hueber5,6. 1. Medizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Deutschland. johannes.knitza@uk-erlangen.de. 2. Rheumatologie, St. Elisabeth-Hospital/Rheinisches Rheuma-Zentrum, Meerbusch-Lank, Deutschland. 3. Rheumatologie, klinische Immunologie und Nephrologie, Asklepios Klinik Altona, Hamburg, Deutschland. 4. Poliklinik, Funktionsbereich und Hiller-Forschungszentrum für Rheumatologie, Heinrich-Heine-Universität Düsseldorf, UKD, Düsseldorf, Deutschland. 5. Medizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Deutschland. 6. Sektion Rheumatologie, Sozialstiftung Bamberg, Bamberg, Deutschland.
Abstract
BACKGROUND: Apps and online platforms play an ever increasing role in the daily work routine of physicians. The aim of this study was to investigate which medical apps and online platforms are used by German rheumatologists for certain tasks and to identify usage trends. METHODS: Data were collected via a SurveyMonkey survey conducted by members of rheumadocs (Young German Rheumatology Association) at the 2016 and 2018 German Society for Rheumatology (DGRh) conferences. RESULTS: In 2016 and 2018 the survey was completed by 75 and 84 assistant and specialist rheumatologists, respectively. In 2016, 37% of rheumatologists were using medical apps in routine care which changed to 49% in 2018. In 2016, 47% compared to 68% in 2018, planned to integrate medical apps into routine care. In total, 20 different medical apps were recommended for colleagues to use; however only 2 of these apps were specific for rheumatology. In contrast to 52 app recommendations for colleagues, only 8 app recommendations for patients were recorded. Most recommendations to physicians received the app "Arznei aktuell" (21%). "Embryotox" was the app, most recommended to patients (38%). In 2016 the online database PubMed was most popular and 97% of participants were familiar with it. Use of other online platforms showed great age dependency in 2016: Amboss (a digital learning platform) was used by 31% of the age group 21-30 years and was not used at all by the age group 51-60 years. DISCUSSION: Use of medical apps and planned integration of medical apps into routine care is increasing among German rheumatologists. On the other hand, recommendable rheumatological apps for rheumatologists and especially for patients are currently largely unknown to rheumatologists.
BACKGROUND:Apps and online platforms play an ever increasing role in the daily work routine of physicians. The aim of this study was to investigate which medical apps and online platforms are used by German rheumatologists for certain tasks and to identify usage trends. METHODS: Data were collected via a SurveyMonkey survey conducted by members of rheumadocs (Young German Rheumatology Association) at the 2016 and 2018 German Society for Rheumatology (DGRh) conferences. RESULTS: In 2016 and 2018 the survey was completed by 75 and 84 assistant and specialist rheumatologists, respectively. In 2016, 37% of rheumatologists were using medical apps in routine care which changed to 49% in 2018. In 2016, 47% compared to 68% in 2018, planned to integrate medical apps into routine care. In total, 20 different medical apps were recommended for colleagues to use; however only 2 of these apps were specific for rheumatology. In contrast to 52 app recommendations for colleagues, only 8 app recommendations for patients were recorded. Most recommendations to physicians received the app "Arznei aktuell" (21%). "Embryotox" was the app, most recommended to patients (38%). In 2016 the online database PubMed was most popular and 97% of participants were familiar with it. Use of other online platforms showed great age dependency in 2016: Amboss (a digital learning platform) was used by 31% of the age group 21-30 years and was not used at all by the age group 51-60 years. DISCUSSION: Use of medical apps and planned integration of medical apps into routine care is increasing among German rheumatologists. On the other hand, recommendable rheumatological apps for rheumatologists and especially for patients are currently largely unknown to rheumatologists.
Entities:
Keywords:
Medical apps; Rheumatology; Telemedicine; eHealth; mHealth
Authors: Nicole L Nollen; Matthew S Mayo; Susan E Carlson; Michael A Rapoff; Kathy J Goggin; Edward F Ellerbeck Journal: Am J Prev Med Date: 2014-04 Impact factor: 5.043
Authors: Liam G Glynn; Patrick S Hayes; Monica Casey; Fergus Glynn; Alberto Alvarez-Iglesias; John Newell; Gearóid OLaighin; David Heaney; Martin O'Donnell; Andrew W Murphy Journal: Br J Gen Pract Date: 2014-07 Impact factor: 5.386
Authors: Elena Nikiphorou; Paul Studenic; Christian Gytz Ammitzbøll; Mary Canavan; Meghna Jani; Caroline Ospelt; Francis Berenbaum Journal: Ann Rheum Dis Date: 2016-10-24 Impact factor: 19.103
Authors: Rachel Knevel; Johannes Knitza; Aase Hensvold; Alexandra Circiumaru; Tor Bruce; Sebastian Evans; Tjardo Maarseveen; Marc Maurits; Liesbeth Beaart-van de Voorde; David Simon; Arnd Kleyer; Martina Johannesson; Georg Schett; Tom Huizinga; Sofia Svanteson; Alexandra Lindfors; Lars Klareskog; Anca Catrina Journal: Front Med (Lausanne) Date: 2022-04-25
Authors: Diana Vossen; Johannes Knitza; Philipp Klemm; Isabell Haase; Johanna Mucke; Anna Kernder; Marco Meyer; Arnd Kleyer; Philipp Sewerin; Gerlinde Bendzuck; Sabine Eis; Martin Krusche; Harriet Morf Journal: Z Rheumatol Date: 2021-08-27 Impact factor: 1.530
Authors: Johannes Knitza; Koray Tascilar; Eva-Maria Messner; Marco Meyer; Diana Vossen; Almut Pulla; Philipp Bosch; Julia Kittler; Arnd Kleyer; Philipp Sewerin; Johanna Mucke; Isabell Haase; David Simon; Martin Krusche Journal: JMIR Mhealth Uhealth Date: 2019-08-05 Impact factor: 4.773
Authors: J G Richter; G Chehab; U Kiltz; A Becker; U von Jan; U-V Albrecht; M Schneider; C Specker Journal: Z Rheumatol Date: 2021-10-11 Impact factor: 1.372
Authors: Johannes Knitza; Till Orlemann; Maximilian Gerner; Nicolas Vuillerme; Timothée Aubourg; Eva-Maria Messner; Yannik Terhorst; Verena Hörmann; Ingo Ganzleben; Hannah Schenker; Georg Schett; Raja Atreya; Markus F Neurath Journal: JMIR Mhealth Uhealth Date: 2022-05-03 Impact factor: 4.947
Authors: Dmytro Fedkov; Andrea Berghofen; Christel Weiss; Christine Peine; Felix Lang; Johannes Knitza; Sebastian Kuhn; Bernhard K Krämer; Jan Leipe Journal: Rheumatol Int Date: 2022-09-16 Impact factor: 3.580
Authors: Johannes Knitza; David Simon; Antonia Lambrecht; Christina Raab; Koray Tascilar; Melanie Hagen; Arnd Kleyer; Sara Bayat; Adrian Derungs; Oliver Amft; Georg Schett; Axel J Hueber Journal: JMIR Mhealth Uhealth Date: 2020-08-12 Impact factor: 4.773
Authors: Martin Krusche; Philipp Klemm; Manuel Grahammer; Johanna Mucke; Diana Vossen; Arnd Kleyer; Philipp Sewerin; Johannes Knitza Journal: JMIR Mhealth Uhealth Date: 2020-07-20 Impact factor: 4.773
Authors: Felix Muehlensiepen; Johannes Knitza; Wenke Marquardt; Jennifer Engler; Axel Hueber; Martin Welcker Journal: J Med Internet Res Date: 2021-03-29 Impact factor: 5.428